EXCERPT:
COLLINS: “We were quite confident that the results of the phase three trials were very clear, but of course, we found out later that there were rare events in the case of the mRNA vaccines of pericarditis, myocarditis. In the case of the Johnson&Johnson vaccine rare events of a clotting disorder. It was too rare to have popped up in 30,000 person trial, so there was no reason to know about the ban, but they ultimately emerged once we got millions and millions of people getting injected. So, yeah even there as we said, the vaccines are safe and effective, it would have been appropriate to say, based upon a study, rigorously done of 30,000 people, that doesn’t rule out the possibility there might be really rare side effects, it could in fact be significant.”